Health Biome is Drug Discovery in South Korea that focus on extensive sporulation business. Founded in 2017. They cover business area such as developer, human microbiota, novel taxa, extensive sporulation, differentiated separation technology, anaerobic intestinal microbe strain, diversify disease, metabolic disease, brain disease, cancer immunotherapy enhancement, physician, multi-omics analysis, clinical research and drug discovery.
2017
( 7 years old in 2024 )
Extensive Sporulation
-
114 Venture Building, Eoeun-dong
125 Gwahak-ro, Yuseong-gu
Daejeon, 34141
South Korea
Private
developerhuman microbiotanovel taxaextensive sporulationdifferentiated separation technologyanaerobic intestinal microbe straindiversify diseasemetabolic diseasebrain diseasecancer immunotherapy enhancementphysicianmulti-omics analysisclinical research and drug discovery
* We use standard office opening hours in near Health Biome's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Health Biome is Drug Discovery business from South Korea that founded in 2017 (7 years old in 2024), Health Biome business is focusing on Extensive Sporulation.
Health Biome headquarter office and corporate office address is located in 114 Venture Building, Eoeun-dong 125 Gwahak-ro, Yuseong-gu Daejeon, 34141 South Korea.
Health Biome was founded in South Korea.
In 2024, Health Biome is currently focus on extensive sporulation sector.
Above is snippet of Google Trends for "extensive sporulation" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Health Biome, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
